BLUE RIBBON POSTER THERAPY: An Innovative Approach Using Ensemble Model Improves Risk Stratification of Ovarian Cancer: A Real World Cohort with PARP Inhibitor Maintaenance Treatment from China
Ovarian cancer, recognized as the most lethal gynecologic malignancy, is frequently detected at advanced stages and is associated with an unfavorable prognosis and heterogeneous therapeutic responses. Poly (ADP-ribose) polymerase inhibitors (PARPi) have revol...
Poster Program · Therapy Physics